Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?

Por Berghoff, Anna S., Preusser, Matthias
Publicado em 2012

In search of a target: PD-1 and PD-L1 profiling across glioma types

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Neuro Oncol (2016)

Targeted Therapies for Melanoma Brain Metastases

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Curr Treat Options Neurol (2017)

Anti-angiogenic therapies in brain metastases

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Memo (2018)

New developments in brain metastases

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Ther Adv Neurol Disord (2018)

New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)

Por Piechutta, Manuel, Berghoff, Anna Sophie
Publicado no ESMO Open (2019)

New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)

Por Starzer, Angelika M., Berghoff, Anna S.
Publicado no ESMO Open (2020)

How I treat anaplastic glioma without 1p/19q codeletion

Por Berghoff, Anna, van den Bent, Martin
Publicado no ESMO Open (2019)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)

Por Oing, Christoph, Starzer, Angelika, Berghoff, Anna
Publicado no Forum (2020)

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Por Preusser, Matthias, Berghoff, Anna S., Wick, Wolfgang, Weller, Michael
Publicado no Clin Neuropathol (2015)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph
Publicado no ESMO Open (2017)

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers

Por Berghoff, Anna Sophie, Stefanits, Harald, Heinzl, Harald, Preusser, Matthias
Publicado em 2012

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Educational video: the role of PD-L1 in the local tumour microenvironment

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2017)

Clinical neuropathology practice news 2-2012: BRAF V600E testing

Por Capper, David, Berghoff, Anna-Sophie, von Deimling, Andreas, Preusser, Matthias
Publicado em 2012

IMMU-26. VISUALIZING TUMOR CELL - LYMPHOCYTE INTERACTIONS IN THE BRAIN METASTATIC CASCADE USING IN VIVO TWO PHOTON MICROSCOPY

Por Piechutta, Manuel, Berghoff, Anna, Karreman, Matthia, Gunkel, Katharina, Wick, Wolfgang, Winkler, Frank
Publicado no Neuro Oncol (2018)

Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers

Por Berghoff, Anna S., Stefanits, Harald, Woehrer, Adelheid, Heinzl, Harald, Preusser, Matthias, Hainfellner, Johannes A.
Publicado em 2013

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

Por Bienkowski, Michal, Berghoff, Anna S., Marosi, Christine, Wöhrer, Adelheid, Heinzl, Harald, Hainfellner, Johannes A., Preusser, Matthias
Publicado no Clin Neuropathol (2015)

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi

Por Tschandl, Philipp, Berghoff, Anna Sophie, Preusser, Matthias, Burgstaller-Muehlbacher, Sebastian, Pehamberger, Hubert, Okamoto, Ichiro, Kittler, Harald
Publicado em 2013

MNGI-28. CORRELATION OF METHYLATION CLASS AND GENETIC ALTERATIONS WITH PROGRESSION FREE SURVIVAL IN MENINGIOMA

Por Berghoff, Anna, Ricken, Gerda, Rajky, Ursula, Marosi, Christine, Hainfellner, Johannes, von Deimling, Andreas, Sahm, Felix, Preusser, Matthias
Publicado no Neuro Oncol (2018)